Global Dengue Rapid Test Market Growth (Status and Outlook) 2023-2029

Global Dengue Rapid Test Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Dengue Rapid Test Industry Forecast” looks at past sales and reviews total world Dengue Rapid Test sales in 2022, providing a comprehensive analysis by region and market sector of projected Dengue Rapid Test sales for 2023 through 2029. With Dengue Rapid Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dengue Rapid Test industry.
This Insight Report provides a comprehensive analysis of the global Dengue Rapid Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dengue Rapid Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dengue Rapid Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dengue Rapid Test and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dengue Rapid Test.
The global Dengue Rapid Test market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Dengue Rapid Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Dengue Rapid Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Dengue Rapid Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Dengue Rapid Test players cover Maternova, Abbott Laboratories, OriGene Technologies, Euroimmun AG, InBios International, NovaTec Immundiagnostica GmbH, Abnova Corporation, Quest Diagnostics and DiaSorin Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Dengue Rapid Test market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
ELISA-Based Test
NS1-Rapid Dengue Test
RT-PCR Amplification Test
Dengue IgG/IgM Rapid Test
Others
Segmentation by application
Medical Hospitals
Diagnostic Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Maternova
Abbott Laboratories
OriGene Technologies
Euroimmun AG
InBios International
NovaTec Immundiagnostica GmbH
Abnova Corporation
Quest Diagnostics
DiaSorin Group
Roche Molecular Systems
Certest Biotec S.L.
Thermo Fisher Scientific

Please note: The report will take approximately 2 business days to prepare and deliver.